Stay updated on Safety of Single Dose UB-221 in Urticaria Clinical Trial
Sign up to get notified when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.

Latest updates to the Safety of Single Dose UB-221 in Urticaria Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe revision tag on the page has been updated from v3.6.5 to v3.6.6. This indicates a minor backend/content update to the page rather than a change to study data or user-facing content.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new Revision: v3.6.5 label was added to the page and the previous Revision: v3.6.4 label was removed, updating the page's version identifier. This reflects an update to the site's software version rather than changes to study content.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page now displays Revision: v3.6.4 in place of the previous v3.6.3, indicating a backend/presentation update without changes to the listed study information.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a small update to the page's documentation/formatting rather than substantive content changes.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page footer now shows Revision: v3.6.2 instead of v3.6.0, indicating a new frontend build without changes to the study information or navigation.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page adds new sections and metadata fields, including Last verified, Last known status was:, How to Read a Study Record, Common Questions, How to Join a Study, and a Revision: v3.6.0 tag. It removes older labels such as Verified, Last known status was:, Intervention / Treatment, and Revision: v3.5.5.SummaryDifference2%

Stay in the know with updates to Safety of Single Dose UB-221 in Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.